The Journal of burn care & rehabilitation
-
A scald burn is a superficial to mid second-degree burn with a viable dermis beneath the blisters and a good blood flow. However, the burn may be incapacitating because of pain and fluid and heat loss. Biobrane adheres very well to this depth of burn and mechanically and biochemically closes the wound. We have used Biobrane on scald burns for the last 5 years and have found it to be an excellent method of treating superficial second-degree burns.
-
Biobrane (standard adherence) and Biobrane L (light adherence) were compared for their degree of adherence to donor site wounds on rabbits at 1, 4, 7, and 9 days. Biobrane, which has more nylon fabric exposed to the wound surface, had significantly greater adherence levels to the wound at all time periods when compared with Biobrane L, which has less nylon fabric exposed to the wound.
-
Biologic dressings remain the gold standard for temporary wound coverage and closure and as a skin substitute. However, increasing interest has resulted in numerous synthetic wound dressings and skin substitutes modeled after biologic dressings. ⋯ Collagen is incorporated in both the silicone and nylon components. The purpose of this conference is to evaluate the effectiveness of Biobrane as a wound dressing with the 15 years of clinical experience used to define the best indications for its present use.
-
Burn-related pain is often severe and intermittently excruciating for months after the initial injury as the result of the multiple procedures these patients must undergo. Procedure-related pain is often undertreated, especially in children. Pain management should be integrated into the patient's overall care plan. ⋯ General anesthesia should be considered, especially in children, when patients are to undergo extremely painful procedures. Patients need not experience severe pain after burn injury. Pain management, especially during very painful procedures, should be an integrated part of patients care and high-quality pain management to improve patient outcome.